Skip to main content
. Author manuscript; available in PMC: 2008 Mar 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2007 Mar;5(3):394–267. doi: 10.1016/j.cgh.2006.12.005

Figure 4. Survival in hepatocellular carcinoma patients by AFP-L3% level and total AFP level.

Figure 4

Figure 4

4A: AFP-L3% level >10% predicts survival of patients with HCC (p=0.0012). 4B: Total AFP >200 ng/ml is a better predictor of survival of HCC patients (p<0.0001). Once total AFP is taken into account, there is no additional prognostic value of the AFP-L3% in this cohort.